Dual GIP/GLP-1 receptor agonist for advanced metabolic research. Novel twincretin mechanism targeting both incretin pathways.
Tirzepatide is a first-in-class dual GIP/GLP-1 receptor agonist — a 39-amino acid synthetic peptide that simultaneously activates glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors. This dual mechanism represents a paradigm shift in metabolic peptide research.
| Product Name | Tirzepatide |
| CAS Number | 2023788-19-2 |
| Purity | ≥98% (by HPLC) |
| Molecular Weight | 4,813.45 g/mol |
| Molecular Formula | C₂₂₅H₃₄₈N₄₈O₆₈ |
| Appearance | White lyophilized powder |
| Storage | Store at -20°C desiccated. Reconstituted solution stable 5 days at 2-8°C. |
| Available Sizes | 5 mg · 10 mg · 15 mg · 30 mg · Custom |
Store at -20°C desiccated. Reconstituted solution stable 5 days at 2-8°C.
24 months from manufacture when stored properly.
Cold-chain shipping with ice packs. Express delivery to 35+ countries.
Get premium research-grade peptides with complete documentation and worldwide delivery.